Zhengyin Yan

Zhengyin Yan

Auto-generated profile, based on publicly available information

Zhengyin Yan

Janssen Research & Development, LLC

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Analytical Chemistry
Verified
Journal Article
Closed access
ZYZhengyin Yan
Zhengyin Yan
LMLi Ma
Li Ma
JHJulie Huang
Julie Huang
PCPasquale Carione
Pasquale Carione
JKJane R. Kenny
Jane R. Kenny
MWMatthew Wright
Matthew Wright

12 January 2024 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
ZYZhengyin Yan
Zhengyin Yan
LMLi Ma
Li Ma
PCPasquale Carione
Pasquale Carione
JHJulie Huang
Julie Huang
NHNicky Hwang
Nicky Hwang
CHCornelis E.C.A. Hop
Cornelis E.C.A. Hop
The well-stirred model (WSM) incorporating the fraction of unbound drug (fu) to account for the effect of plasma binding on intrinsic clearance has been widely used for predicting hepatic clearance under the assumption that drug protein binding reaches equilibrium instantaneously. Our theoretical analysis reveals that the effect of protein binding on intrinsic clearance is better accounted for with the dynamic free fraction (fD), a measure of drug protein binding affinity, which leads to a putative dynamic well-stirred model (dWSM) without the instantaneous equilibrium assumption. Using recombinant CYP3A4 as the in vitro clearance system, we demonstrate that the binding effect of albumin on the intrinsic clearance of both highly bound midazolam and highly free verapamil is fully corrected by their corresponding fD values, respectively. On the other hand, fu only corrects the binding effect of albumin on the intrinsic clearance of verapamil, and yields severe over-correction of the intrinsic clearance of midazolam. The results suggest that the traditional WSM is suitable for highly free drugs like verapamil but not necessarily for highly bound drugs such as midazolam due to the violation of the instantaneous equilibrium assumption or under-estimating the true free drug concentration. In comparison, the dWSM incorporating fD holds true as long as drug elimination follows steady-state kinetics, and hence, it is more broadly applicable to drugs with different protein binding characteristics. Here we demonstrate with 36 diverse drugs, that the dWSM significantly improves the accuracy of predicting human hepatic clearance and liver extraction ratio from in vitro microsomal clearance data, highlighting the importance of drug plasma protein binding kinetics in addressing the under-prediction of hepatic clearance by the WSM.

1 January 2004
Verified
Book Chapter
Closed access
PDF file
ZYZhengyin Yan
Zhengyin Yan
GCGary W. Caldwell
Gary W. Caldwell

1 January 2018 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
SWSusan Wong
Susan Wong
UDUtkarsh Doshi
Utkarsh Doshi
PVPeter Vuong
Peter Vuong
NLNing Liu
Ning Liu
STSuzanne Tay
Suzanne Tay
ZYZhengyin Yan
Zhengyin Yan